Lilly’s Verzenio (abemaciclib) Significantly Extended Life in Women with HR+, HER2- Advanced Breast Cancer in MONARCH 2 Read more
Exclusive Interview with AstraZeneca’s Former VP, Medical Evidence & Observational Research Read more
Epizyme Announces FDA Filing Acceptance of New Drug Application and Priority Review for Tazemetostat for the Treatment of Epithelioid Sarcoma Read more